Phio Pharmaceuticals Corp. (PHIO)
1.17
-0.08
(-6.40%)
USD |
NASDAQ |
Mar 13, 16:00
1.19
+0.02
(+1.71%)
After-Hours: 20:00
Phio Pharmaceuticals Enterprise Value : -7.439M for March 13, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -108.92M |
| Jaguar Health, Inc. | 30.23M |
| MetaVia, Inc. | 26.70M |
| Seastar Medical Holding Corp. | -4.035M |
| Jupiter Neurosciences, Inc. | 13.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.371M |
| Total Expenses (Quarterly) | 2.371M |
| EPS Diluted (Quarterly) | -0.2041 |
| Earnings Yield | -128.5% |
| Normalized Earnings Yield | -128.54 |